Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atea Pharmaceuticals (AVIR) Return on Equity: 2021-2022

Historic Return on Equity for Atea Pharmaceuticals (AVIR) over the last 2 years, with Sep 2022 value amounting to 0.05%.

  • Atea Pharmaceuticals' Return on Equity rose 1.00% to 0.05% in Q3 2022 from the same period last year, while for Sep 2022 it was 0.05%, marking a year-over-year increase of 1.00%. This contributed to the annual value of 0.19% for FY2021, which is N/A change from last year.
  • According to the latest figures from Q3 2022, Atea Pharmaceuticals' Return on Equity is 0.05%, which was up 132.54% from 0.02% recorded in Q2 2022.
  • In the past 5 years, Atea Pharmaceuticals' Return on Equity ranged from a high of 0.19% in Q4 2021 and a low of 0.02% during Q2 2022.
  • Its 2-year average for Return on Equity is 0.07%, with a median of 0.05% in 2022.
  • Within the past 5 years, the most significant YoY rise in Atea Pharmaceuticals' Return on Equity was 2bps (2022), while the steepest drop was 4bps (2022).
  • Over the past 2 years, Atea Pharmaceuticals' Return on Equity (Quarterly) stood at 0.19% in 2021, then climbed by 1bps to 0.05% in 2022.
  • Its last three reported values are 0.05% in Q3 2022, 0.02% for Q2 2022, and 0.07% during Q1 2022.